Global Coalition on Aging Calls on Governments, Health Systems, Employers, and Other Stakeholders to Prioritize Action on Eye Health

New paper challenges prevailing view that vision loss is a normal consequence of aging and warns about the fiscal unsustainability of inaction.

(New York –May 2, 2019) – Today, the Global Coalition on Aging (GCOA) released a new white paper, titled A Life Course of Healthy Vision: A Critical Priority for the 21st Century, which upends the prevailing view of deteriorating vision as an inevitable consequence of aging and examines the health and economic impacts of visual impairment and vision loss. The paper calls on policymakers, health systems, employers, and advocates alike to prioritize action to reduce the global burden of visual impairment and vision loss.

“For far too long, deteriorating vision has been accepted as simply a normal part of growing older,” said Michael W. Hodin, PhD, CEO of GCOA. “While we know that the vast majority of vision loss is among those over 50 – the fastest growing demographic group, globally – we also know that a full 80% of declining vision is avoidable with appropriate eye care, prevention, early intervention, and treatment. Because of the devastating impact of vision loss on functional ability, independence, quality of life, worker productivity, and, therefore, economic growth, government and employers alike must recognize the urgent need to interrupt our current trajectory. Failure to do so will be fiscally unsustainable for us all.”

In 2017, there were 253 million people worldwide who were considered visually impaired. This number is expected to more than double to 587.6 million by 2050, and the number of those with vision loss is expected to triple in this same time period. Visual impairment and vision loss are uniquely expensive, above and beyond the costs of direct medical care, as a result of the loss of independence that often follows. By next year, the indirect costs of visual impairment are expected to total $760 billion, largely due to increased care needs and lost productivity.

“Visual impairment and vision loss are devastating for the individual, who may no longer be able to work or to live independently and may now be at greater risk for depression, Alzheimer’s, and falls, among other health challenges,” said Dr. James Tsai, President of New York Eye and Ear Infirmary of Mount Sinai. “And because of the important connection between eye health and the rest of the body, expanding our capacity to provide eye care can also yield important advances in our ability to diagnose and manage other health conditions, including neurological diseases, hypertension, and diabetes. Prioritizing vision on the health and economic policy agendas has the potential to yield exponential benefits.”

The white paper is based on insights from GCOA’s December 2018 Life Course of Healthy Vision roundtable, which brought together experts and advocates from the fields of eye health, aging, healthcare, business, technology, and academia. The paper identifies barriers to adequate eye care, including ageism, health system silos,treatment burden, strained capacity, and policy,and calls for immediate action across five key pillars:

  • Access and Capacity: Health systems must develop strategies to increase access to regular eye care and necessary treatments as well as increase the capacity of professionals across the care ecosystem to provide screening, prevention, and specialty care.
  • Financing: Policymakers must ensure that funding mechanisms support and incentivize wider access to high-quality eye care.
  • Research: To address the growing burden of visual impairment and vision loss, we must enable ongoing innovation in treatments, technologies, and interventions.
  • Education:Increasing literacy about basic eye health and the close connection between eye health and other health conditions are critical for both healthcare professionals and the public.
  • Workplace:Employers have an important opportunity and an interest in supporting eye health through wellness and screening initiatives, ensuring that our workforces remain healthy and productive at every age.

As momentum builds in preparation for the World Health Organization Decade of Healthy Ageing (2020-2030), member states, employers, and stakeholders around the world have a critical window of opportunity to recognize that healthy vision is an indispensable and underrecognized component of healthy aging and to commit to actions that prioritize a life course of healthy vision for all.

To read the full report, click here.

Latest Developments

We keep our members and partners in touch with the most recent updates and opinions in the worldwide dialogue on population longevity and related issues.

What Old Age Might Be Like for Today’s 30-Year-Olds

Get ready for a new old age. With the U.S. fertility rate in a decadelong slump and the life expectancy of 65-year-old Americans approaching roughly 85, our aging nation is likely to grow older by midcentury, as the ratio of young to old continues to decline. The trend is likely to upend how our society is organized, making life very different for today’s 30-year-olds when they reach their 60s compared with life for 60-year-olds now.

World Population Reaches 8bn As It Grows Older

The world’s population reached 8bn people on Tuesday and will hit 9bn in 15 years as it experiences an unprecedented surge in the number of older people, according to the latest UN data. The global fertility rate has more than halved since the 1950s to 2.3 births per woman. With mortality also falling, the number of people aged 65 and over is expected to rise from 783mn in 2022 to 1bn by 2030 and reach 1.4bn by 2043, the UN population data revealed.

Global Coalition on Aging (GCOA) Launches Cross-Sector Alliance Committed to Health Innovation at High-Level Forum on The Silver Economy

Today, the Global Coalition on Aging (GCOA), along with cross-sector stakeholders representing patient advocacy, policy, industry, and academic communities, announced the launch of the Alliance for Health Innovation at the High-Level Forum on the Silver Economy in New York. The Alliance is dedicated to establishing the importance of innovation in achieving healthy aging and health equity through investments, policy reforms, and strategic partnerships.

Japan Must Face Up to Growing Danger of Drug-resistant Germs

In the wake of more than 6.4 million COVID-19 deaths worldwide and unprecedented economic destruction, the global community has no excuse to be caught unprepared for the next pandemic. Yet right now, a devastating parallel plague is already underway and worsening. Some years, it is killing well over 1 million people, according to medical journal The Lancet.

A Bipartisan Bill Could Prevent The Next Pandemic

In Washington, Republicans and Democrats are typically at loggerheads when it comes to healthcare policy. Just consider the recent Inflation Reduction Act, which made extensive changes to Medicare and also extended Affordable Care Act subsidies. Every single congressional Democrat voted for the legislation, while every single member of the GOP voted against it. But occasionally, a bill is such an obviously good idea, and so desperately needed, that it commands significant bipartisan support. The PASTEUR Act, co-sponsored by 31 Democrats and 31 Republicans in the House and two members of each party in the Senate, is just such a bill.

Korea Must Act Now to Combat Growing AMR Threat

Public officials are overlooking one of the gravest long-term threats to the Korean people, the health system, and economy: antimicrobial resistance (AMR). Some pathogens ― bacteria, fungi, parasites, and viruses ― have evolved strains that resist the antimicrobial medications we currently have available to fight them. Health care professionals often must watch helplessly as patients succumb to infections that antibiotics could once have easily beaten. They know that new antimicrobials, including and especially antibiotics, could easily gain the victory ― but they have none at their disposal.

Policy Statement on the Impact of Price Negotiations on Innovation, Healthy Aging and Equity

As the CEO of the Global Coalition on Aging (GCOA) and a newly formed cross-sector Alliance for Health Innovation, we write to express our deep concern with the current legislation that allows for price “negotiations” in Medicare – a thinly veiled signal for America’s plunge into price controls that will have a devastating and adverse impact on biopharmaceutical innovation and our nations’ ability to support healthy aging.